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The H3N2 vaccine strain (A/Panama/2007/99) for the 2003–2004 influenza season did not antigenically match the circulating A/Fujian/
411/02-like H3N2 viruses and had reduced effectiveness against influenza outbreaks. A/Wyoming/03/2003, an A/Fujian-like virus, was
recommended as the vaccine strain for the 2004–2005 season. A/Wyoming differed from A/Panama by 16 amino acids in the HA1 molecule.
Reverse genetics was used to determine the minimal amino acid changes that were responsible for the antigenic drift from A/Panama to A/
Wyoming. After substitutions of 2 of the 16 amino acids in the HA (H155T, Q156H), the A/Panama HA variant was antigenically equivalent
to A/Wyoming as determined by hemagglutination inhibition and microneutralization assays using ferret postinfection antisera. Conversely,
A/Wyoming containing the His-155 and Gln-156 residues from A/Panama was antigenically equivalent to A/Panama. These results indicated
that only these two HA residues specified the antigenic drift from A/Panama to A/Wyoming; other amino acid differences between these two
H3N2 viruses had minimal impact on virus antigenicity but impacted virus replication efficiency in eggs.
D 2005 Elsevier Inc. All rights reserved.
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Influenza virus infects approximately 20% of the human
population each year and causes significant morbidity and
mortality worldwide (Stohr, 2002). Vaccination is the
primary method for prevention of the disease. The ability
of influenza virus to constantly alter its antigenic properties
has made it very difficult to control this highly contagious
respiratory illness. The hemagglutinin (HA) and neurami-
nidase (NA) surface glycoproteins are the most important
antigens for inducing protective antibody responses. Accu-
mulating mutations of the HA and NA genes, a process
called antigenic drift, enable viruses to escape from
immunity induced by prior infection or vaccination resulting
in recurring annual epidemics of influenza. Effective0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: jinh@medimmune.com (H. Jin).vaccination can only be achieved when the vaccine strains
are antigenically similar to the circulating strains, which
requires that the antigens in influenza vaccines be updated
frequently to provide ultimate protection.
The HA gene undergoes an elevated mutation rate
compared to other genes (Plotkin and Dushoff, 2003),
indicating that immune selection plays an important role in
the evolution of HA. Proteolytic cleavage of the single
polypeptide precursor (HA0) generates two polypeptides
(HA1 and HA2) (Lamb and Krug, 2001). The 3D structure
of the HA homotrimer of A/Aichi/2/68 (H3N2) has been
determined and five major antigenic sites on the HA1 have
been mapped (Kilbourne, 1969; Wiley et al., 1981; Wilson
and Cox, 1990). A large number of amino acid changes
associated with antigenic drift have been mapped to the
hydrophilic surface of the HA1 subunit (Bush et al.,
1999b) based on the surveys of both natural and
laboratory-selected antigenic variants of H3N2 strains.
Various studies have indicated that the amino acids located05) 113–119
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had greater variability, higher ratio of sense mutation, and
greater correlation with the change of virus antigenicity
(Bush et al., 1999a; Lee and Chen, 2004). Wilson and Cox
have proposed that a drift variant of epidemiological
importance usually requires changes of at least four amino
acids across two or more antigenic sites (Wilson and Cox,
1990). Rarely, a single amino acid substitution at one
antigenic site can also cause sufficient antigenic change
(Smith et al., 2004). The ability to understand the
mechanistic basis for antigenic drift and the basis of
antigenic difference between two related strains could
ultimately improve the selection of vaccine strains (Bush et
al., 1999a; Ellis et al., 1995; Lee and Chen, 2004; Plotkin
and Dushoff, 2003; Plotkin et al., 2002).
Inactivated influenza vaccines consist of HA and NA
molecules as major immunogenic components of the
vaccine and generally provide protection from illness when
vaccine antigens and circulating viruses share a high degree
of similarity in HA. The H3N2 vaccine strain for the 2003–
2004 influenza season (A/Panama/2007/99) did not anti-
genically match the circulating A/Fujian/411/02(H3N2)-
like viruses and had reduced effectiveness against A/
Fujian-like virus-caused illness (CDC, 2004a, 2004b). A/
Wyoming/03/2003 is an A/Fujian-like virus and recom-
mended as the vaccine strain for the 2004–2005 season. A/
Wyoming differed from A/Panama by 16 amino acids in
the HA1 molecule. Reverse genetics was used to determine
the minimal amino acid changes that were responsible for
causing antigenic drift from A/Panama to A/Wyoming. The
amino acids differing between these two strains were
examined by introducing specific amino acid changes into
the HA gene and evaluating their impact on antigenicity.
The data showed that a minimum of two HA residues were
required for causing the antigenic drift from A/Panama to
A/Wyoming.Results
Generation and replication of recombinant 6:2 reassortant
recombinant viruses
A/Panama and A/Fujian differed from each other by 13
amino acids in the HA1 region (Table 1). A/Wyoming,
which is antigenically similar to A/Fujian, had three
additional amino acid changes in the HA1 compared to
that of A/Fujian. These three HA residues in A/Wyoming
enabled efficient virus replication in embryonated chicken
eggs (Lu et al., 2005). Ten of the 16 amino acid differences
between A/Panama and A/Wyoming are located in the distal
head of the HA trimer in close proximity of the HA receptor
binding sites or the five main antigenic regions (Fig. 1,
Table 1). To determine which of these changes played a role
in antigenic drift from A/Panama to A/Wyoming, eight
amino acids positioned near the antigenic sites were chosenfor evaluation; two positions (128 and 219) were not
evaluated because they have been shown previously to
have no impact on antigenicity (Lu et al., 2005). Three of
the HA residues, 183, 222, and 225, are not located at the
known antigenic sites, but these residues might affect virus
replication in eggs (Lu et al., 2005). Therefore, these three
residues were also substituted together with the neighboring
residues.
The A/Wyoming HA-specific amino acids were intro-
duced individually or in combination into the A/Panama HA
and a total of eight 6:2 recombinant viruses, containing the
internal genes of MDV-A, the A/Panama NA, and the
mutant A/Panama HA, were obtained (Table 1). The HA
sequence of each virus was verified by sequencing. Except
for F345 containing a single H155T change, all recombi-
nants replicated well in MDCK cells; F345 achieved a titer
of only 2.8 log10PFU/ml in MDCK cells. The recombinants
replicated to varying extents in embryonated chicken eggs.
F279 containing the L183H and S186V changes in HA
grew well in eggs, however, the virus isolated from the eggs
after one passage contained a mutation in an adjacent
residue (V182F). The F280 recombinant, with the H155T
and Q156H changes, did not grow well in the eggs initially.
Following several rounds of passage in eggs, a variant that
had an additional change at P185L in the HAwas recovered;
the resulting virus achieved high titers in eggs. F345 with
H155T change was not recovered from eggs.
Residues 155 and 156 controlled antigenicity of A/Panama
HA variants
The antigenicity of the recombinant A/Panama HA
variants was examined by the HAI assay using A/Wyoming
and A/Panama post-infection ferret antisera (Table 1). The
A/Wyoming and A/Panama ferret antisera easily distin-
guished A/Wyoming from A/Panama, having 16-fold differ-
ence in the HAI titer. To eliminate any potential impact of
egg-adapted mutations on the antigenicity of recombinants
F279 and F280, these two viruses grown in MDCK cells
(F279M and F280M) were also included in the HAI assay.
Based on the cross-reactive HAI titers shown in Table 1,
mutants F274, F275, F277, F278, F279, and F279M
behaved antigenically like A/Panama and mutants F276,
F280, and F280M behaved antigenically like A/Wyoming.
Microneutralization assay was also performed with these
recombinant viruses using postinfection ferret sera against
A/Wyoming or A/Panama. Only F276 and F280 had
microneutralization titer similar to A/Wyoming and the
other viruses had titers similar to A/Panama (data not
shown). Thus, recombinant F280 contained only the H155T
and Q156H changes within the context of the A/Panama
HA, yet was antigenically similar to A/Wyoming, indicating
that these two residues were critical for converting the
antigenicity.
To further determine whether the residues 155 and 156
controlled virus antigenicity and to confirm that the P185L
Table 1
Comparisons of HA sequence, virus replication, and antigenicity of A/Fujian, A/Wyoming, and A/Panama HA variants
Virus Amino acids at the indicated HA positionsa Replication in eggs
(log10PFU/ml)
HAI titer (Ag difference)b
21 25 50 75 83 128 131 155,6 183 186 202 219 222,5,6 Anti-A/Wyoming Anti-A/Panama
C E E B A B B B D D
A/Panama/2007/99 S L R H E T A HQ L S V S WGV 7.8 128 (16-fold) 1024 (Ref)
A/Fujian/411/02 P I G Q K – T TH H G I – RD– 4.0 NDc ND
A/Wyoming/03/03 P I G Q K A T TH H V I Y RDI 8.0 2048 (Ref) 256 (4-fold)
F274 –d – G Q K – – –– – – – – ––– 8.2 64 (32-fold) 1024 (b2-fold)
F275 – – – – – – T –– – – – – RDI 8.4 64 (32-fold) 512 (2-fold)
F276 – – – – – – T TH – – – – RDI 8.8 1024 (2-fold) 256 (4-fold)
F277 – – – – – – T –– – – – – ––– 7.9 64 (32-fold) 1024 (b2-fold)
F278 – – – – – – – –– – – – – RDI 7.4 32 (64-fold) 512 (2-fold)
F279Me – – – – – – – –– H V – – ––– NAf (6.1 MDCK) 128 (16-fold) 512 (2-fold)
F279 (V182F) – – – – – – – –– H V – – ––– 8.7 128 (16-fold) 1024 (b2-fold)
F280Me – – – – – – – TH – – – – ––– b2.0 (6.1 MDCK) 2048 (b2-fold) 512 (2-fold)
F280 (P185L) – – – – – – – TH – – – – ––– 8.1 2048 (b2-fold) 512 (2-fold)
F345Me – – – – – – – T– – – – – ––– b2.0 (2.8 MDCK) ND ND
a The HA sequence of the indicated virus was examined by sequencing of the RT/PCR-amplified DNA using vRNA as template. The residues located in the five antigenic sites (A, B, C, D, and E) are indicated
(Bush et al., 1999a).
b Ferret postinfection serum against A/Wyoming or A/Panama was tested with the indicated virus antigen by the HAI assay and the HAI titer (averaged from two animals for anti-A/Wyoming) was the reciprocal of
the highest serum dilution that inhibited hemagglutination. Antigenic difference of different viruses compared to the reference strain is expressed as the fold difference and the viruses having 4-fold or greater
difference are underlined.
c ND, not determined due to low virus titer.
d Same as A/Panama.
e Indicates those that did not replicate well in eggs.
f Not applicable.
H
.
Jin
et
a
l.
/
V
iro
lo
g
y
3
3
6
(2
0
0
5
)
11
3
–
11
9
1
1
5
Fig. 1. Location of the 16 residues differed between A/Panama and A/
Wyoming on the H3 HA 3D structure (Wilson et al., 1981). The residues
located in antigenic site A are labeled as blue, site B as red, site C as purple,
site D as yellow, and site E as green. Those labeled as back are not present in
the antigenic sites. Residue 202 is buried. Residues 21, 25, 202, and 209
were not mutated in this study.
Fig. 2. Antigenicity of A/Panama HA variants. F276 and F280 grown in
eggs and F280M amplified in MDCK cells were used to infect ferrets
intranasally and the sera were collected 21 days after infection. The HAI
titers of the postinfection ferret sera against the A/Panama and A/Wyoming
antigens were determined and the geometric mean titers from two serum
samples are shown. F276-, F280-, and F280M-infected serum preferentially
reacted with A/Wyoming than A/Panama.
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not affect virus antigenicity, F280, F280M, and F276 were
used to infect ferrets through the intranasal route and sera
were collected 21 days postinfection. The antibody titers of
the infected ferret sera were measured by the HAI assay
using the A/Panama and A/Wyoming antigens, and the
homologous viral antigens, respectively. As shown in Fig. 2,
sera from ferrets infected with F276, F280, or F280M
recognized A/Wyoming preferentially to A/Panama. Using
the Archetti–Horsfall methods (Archetti and Horsfall,
1950), F276 and F280 were 100% antigenically related to
A/Wyoming and 25% related to A/Panama. There was no
difference in the antigenicity between the two F280 viruses
grown in eggs (F280) with the P185L mutation or grown in
MDCK cells (F280M). This experiment further demonstra-
ted that the two amino acid changes at residues 155 and 156
of the HA of A/Wyoming were responsible for the antigenic
drift from A/Panama to A/Wyoming. The egg-adapted
P185L change had no effect on antigenicity in the presence
of the 155 and 156 residues derived from A/Panama.
Residues at 155 and 156 controlled antigenicity of the HA
molecules.
Both 155 and 156 residues were required for the antigenic
drift
Recombinant F345 carrying the single H155T change in
A/Panama HA grew extremely poorly in MDCK cells andwas unable to grow in eggs (Table 1). In addition, a
recombinant virus carrying only the Q156H change could
not be recovered from the transfected plasmids. Therefore,
it was not possible to determine the individual impact of
residues 155 and 156 using the A/Panama variants. Thus, a
few of the converse mutants were made by introducing the
A/Panama HA 155 and 156 residues into A/Wyoming
singly or in combination to test their effect on virus
antigenicity. Three viruses, A/Wyoming-HH, A/Wyoming-
TQ, and A/Wyoming-HQ, were obtained (Table 2). All of
these three viruses grew well in MDCK cells and eggs.
However, the single His-155 change in the HA of A/
Wyoming-HH rapidly reverted to Tyr-155 after a single
round of amplification in eggs, indicating that the HA
containing two histidines (His-155 and His-156) in this
region was unstable. Therefore, the MDCK-grown
recombinants were tested in the HAI assay and shown to
have antigenicity similar to those that could be produced in
eggs. Recombinant virus with either single site mutation
(HH and TQ) had antigenicity intermediate between A/
Wyoming and A/Panama. A/Wyoming-HQ with double
T155H and H156Q mutations was antigenically more
similar to A/Panama (Table 2). In addition, the micro-
neutralization assay was also performed to examine the
antigenicity of these three viruses (Table 2). The A/
Wyoming variants carrying the single or double A/Panama
155 and 156 residues had antigenicity difference of 4-fold
or higher compared to A/Wyoming when measured with
anti-A/Wyoming serum. Using the A/Panama ferret serum,
the antigenicity of single mutants was 5.6-fold and 4-fold
different from A/Panama, but the double mutant (A/
Wyoming-HQ) carrying both 155 and 156 residues from
A/Panama had antigenicity identical to A/Panama. Thus,
the microneutralization data further confirmed that both
Table 2
Antigenicity of A/Wyoming HA variants
Test antigen HA residues HAI titer (antigenic difference)a MicroNeut titer (antigenic difference)b
155 156 Anti-A/Wyoming Anti-A/Panama Anti-A/Wyoming Anti-A/Panama
A/Wyoming/03/03 T H 2048 (Ref) 1024 (4-fold) 5120 (Ref) 113 (11-fold)
A/Panama/2007/99 H Q 128 (16-fold) 4096 (Ref) 320 (16-fold) 1280 (Ref)
A/Wyoming-HH H H 512 (4-fold) 2048 (2-fold) 1280 (4-fold) 226 (5.6-fold)
A/Wyoming-TQ T Q 512 (4-fold) 2048 (2-fold) 640 (8-fold) 320 (4-fold)
A/Wyoming-HQ H Q 256 (8-fold) 4096 (b2-fold) 1280 (4-fold) 1280(b2-fold)
Antigenic difference of each variant relative to the reference virus (Ref) is expressed as the fold difference and those having HAI titer of 4-fold or greater are
underlined.
a Postinfection sera from ferrets infected with A/Wyoming (two animals) or A/Panama (one animal) were tested with the indicated virus antigen by the HAI
assay and the HAI titer was the reciprocal of the highest serum dilution that inhibited hemagglutination.
b The level of neutralizing antibody in postinfection sera against A/Wyoming and A/Panama was measured by the microneutralization assay and the geometric
mean titers of the duplicate tests were calculated.
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antigenic drift from A/Panama to A/Wyoming.Discussion
Influenza viruses constantly drift to evade host immunity.
Among the 16 amino acid changes between HAs of A/
Panama and A/Wyoming, 10 amino acids were located at
the proposed five antigenic sites. This study demonstrated
that not all the amino acids located in the five antigenic sites
were responsible for causing antigenic drift from A/Panama-
like to A/Wyoming-like viruses in the ferret model. A
change of as few as two amino acids (H155T and Q156H)
could result in significant antigenic drift from A/Panama to
A/Wyoming.
The residues 155 and 156 are located in the tip of the HA
structure and are easily accessible to antibodies. Since 1968,
when the first influenza H3N2 strain emerged in humans,
residues 155 and 156 have gone through significant
evolution, from the original TK of A/HK/68 to YK, YE,
HE, HK, HQ, and TH in the HA of the current A/Fujian/
411/02-like strains. The frequent changes of these two
residues most likely correlated with the antigenic drift of
these H3N2 viruses in the past. Replacing the 155 and 156
residues of A/Panama HA with those of A/Wyoming
restricted virus replication in eggs. However, A/Wyoming
that contained the 155 and 156 residues from A/Panama
grew efficiently in eggs. These data indicated that mutations
in the HA tip region at these two residues affected virus
replication differently. Growth of the A/Memphis/7/90
H3N2 strain in eggs selected an E156K variant that had
the altered antigenicity (Kodihalli et al., 1995), supporting
the notion that residue 156 plays an important role in
defining virus antigenic characteristics and influences virus
replication in eggs.
A/Fujian/411/02 did not grow well in eggs. We have
recently shown that a minimum of two amino acid changes
at positions 183 and 226 or 186 and 226 could enable A/
Fujian to replicate in eggs (Lu et al., 2005). The changes at
residues183, 186, and 226 have been found to increase theHA receptor binding affinity without affecting virus anti-
genicity (Kodihalli et al., 1995; Lu et al., 2005). The amino
acids in this region are involved in HA receptor binding
activity (Rogers et al., 1983; Weis et al., 1988) and correlate
with virus growth in embryonated chicken eggs as reported
previously (Kodihalli et al., 1995; Rocha et al., 1993).
However, our study showed that introduction of the S186V
and V226I changes into the HA of recombinant F280, along
with T155 and H156 residues, did not result in virus
recovery (data not shown). It was found that the P185L
change in the receptor-binding region acquired during egg
growth was sufficient to make the A/Panama virus variant
with the T155 and H156 residues grow efficiently in eggs.
A/Panama containing HA residues from A/Wyoming at
positions 131, 222, 225, and 226, in addition to the 155 and
156 residues, replicated efficiently in eggs, suggesting these
four changes are important for A/Wyoming to replicate
efficiently in the hosts.
From antigenic variation studies of influenza A viruses, it
has been proposed that at least four amino acid changes
across two or more antigenic sites in the HA were required
to result in a drifted variant to be epidemically important
(Wilson and Cox, 1990), although exceptions exist (Smith et
al., 2004). The drifted A/Fujian strain had 13 amino acid
changes across the five antigenic sites, but they were not
equally important for the antigenic drift. It was possible that
some of the residues might play a much less dominant role
than the 155 and 156 resides in the antigenic site B, which
we were not able to detect using the ferret antisera. Residue
131 is located in the antigenic site A region and has not
undergone significant change, either Thr or Ala has been
present at this position for the H3N2 strains since 1968.
F277 that had the A131T change in A/Panama had
antigenicity very similar to that of A/Panama. Residue 50
in antigenic site C and residues 75 and 83 in site E had little
antigenic effect. Therefore, only the 155 and 156 residues in
the antigenic site B region were critical to antigenic drift.
Previously, it was also suggested that a single amino acid
located in the antigenic site such as the N145K change
could cause antigenic change (Smith et al., 2004), support-
ing the notion that some of the HA residues have a larger
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for antigenic drift.
Postinfection ferret serum has been extensively used in
identifying antigenically drifted influenza strains during the
vaccine strain selection process. The ferret antiserum
following infection with A/Wyoming distinguished A/
Wyoming and A/Panama very well, exhibiting a 16-fold
difference in the HAI titer. However, ferret antiserum for A/
Panama only had a 4-fold or less difference in the HAI titer
between these two antigenically drifted viruses. A recent
study has demonstrated that live attenuated influenza
FluMist vaccine that contained A/Panama H3N2 vaccine
administered intranasally had a broader immune response
against the drifted A/Wyoming strains compared to the
inactivated influenza vaccine (Mendelman et al., 2004),
which is consistent with the data reported here. It remains to
be determined whether the data obtained with the ferret
postinfection serum correlate well with the postinfection
human serum. Postinfection sera from mice infected with A/
Wyoming and A/Panama were not able to distinguish these
two antigenically different strains (data not shown). There-
fore, different hosts may react with antigenic epitopes
differently.
In conclusion, this study showed that reverse genetics is
powerful for defining the molecular determinants of anti-
genic drift at the level of individual amino acids. The two
amino acid changes at positions 155 and 156 in the HA1
altered the antigenicity of influenza A H3N2 viruses.
Monitoring of these two amino acid residues annually
between the recommended vaccine and the circulating
strains and during vaccine manufacturing is strongly
recommended.Materials and methods
Virus strains, cells, and antisera
Wild-type (wt) influenza A virus strains, A/Panama/
2007/99 (A/Panama), A/Fujian/411/02 (A/Fujian), and A/
Wyoming/03/03 (A/Wyoming), were obtained from the
Centers for Disease Control (CDC, Atlanta, GA) and
amplified once in MDCK cells or in embryonated chicken
eggs. COS-7 and MDCK cells (obtained from American
Type Culture Collections, ATCC) were maintained in
minimal essential medium (MEM) containing 5% fetal
bovine serum (FBS). Post-infection ferret sera against A/
Wyoming, A/Panama, or HA variants in groups of 2 animals
were produced by intranasal infection with 7.0 log10PFU of
influenza virus and the sera were collected 21 days
postinfection.
cDNA cloning and mutagenesis of the HA molecules
The HAs and NAs of A/Panama and A/Wyoming were
amplified from viral RNA by RT/PCR using HA- and NA-specific primers containing AarI restriction enzyme sites
(Lu et al., 2005). The AarI restriction sites were designed to
be comparable with the BsmBI sties in the pAD3000 pol I/
pol II expression vector (Hoffmann et al., 2000; Jin et al.,
2003). The HA and NA cDNA sequences of A/Panama and
A/Wyoming were determined and the cDNA clones that had
sequence identical to those of wt viruses were used. Amino
acid substitution mutations of the HA cDNA of A/Panama
or A/Wyoming were performed using the QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA).
Generation of recombinant 6:2 reassortants
The HA and NA of H3N2 influenza virus were
reassorted with cold-adapted A/AA/6/60, the master donor
virus (MDV-A) for live attenuated influenza A vaccines, by
plasmid rescue using the previously described procedures
(Hoffmann et al., 2000; Jin et al., 2003). Briefly, a set of six
plasmids containing the 6 internal genes of MDV-A (Jin et
al., 2003) together with the HA and NA expression plasmids
was transfected into the co-cultured COS-7/MDCK cells
using TransIT LT1 reagents (Mirus, Madison, WI). The
supernatant of the transfected cell culture was collected 3
days post-transfection and used to infect fresh MDCK cells
and 10-day-old embryonated chicken eggs. The infected
MDCK cells were incubated at 33 8C until 80–90% cells
exhibited a cytopathic effect. The infected embryonated
chicken eggs were incubated at 33 8C for 3 days and the
allantoic fluids were collected and stored at 70 8C in the
presence of SPG stabilizer (0.2 M sucrose, 3.8 mM
KH2PO4, 7.2 mM K2HPO4, 5.4 mM monosodium gluta-
mate). The HA sequence was verified by sequencing the
RT/PCR-amplified cDNA using viral RNA as template.
Virus titer was determined by plaque assay on MDCK cells
incubated under an overlay that consisted of 1 L15/MEM,
1% agarose, and 1 Ag/ml TPCK-trypsin at 33 8C for 3 days.
The infected cells were fixed with 100% methanol and the
plaques were enumerated by immunostaining using A/AA/
6/60-immunized chicken serum.
Hemagglutination inhibition reactions of influenza variants
Virus antigenicity was analyzed by hemagglutination
inhibition (HAI) assay using A/Panama- or A/Wyoming-
infected ferret sera. Groups of two male seronegative ferrets,
9–10 weeks old, obtained from Triple F farms (Sayre, PA)
were lightly anesthetized with isoflurane and inoculated
intranasally with 7.0 log10PFU of virus in 1.0 ml of volume.
At 21 days postinfection, ferret sera were collected and
treated with receptor destroying enzyme (RDE, Kenka
Seiken, Tokyo, Japan) at 37 8C overnight according to the
manufacturer’s instruction. For HAI assay, 25-Al aliquots of
2-fold serially diluted RDE-treated ferret sera were incu-
bated with 25-Al virus containing 4 HA units of 6:2
reassortant viruses at 37 8C for 1 h followed by incubation
with 50 Al of 0.5% turkey red blood cells at 25 8C for 45
H. Jin et al. / Virology 336 (2005) 113–119 119min. The HAI titer was defined as the reciprocal of the
highest serum dilution that inhibited hemagglutination.
Microneutralization assay
A/Panama variants were also examined by microneutral-
ization assay using postinfection ferret sera. Aliquots of 2-
fold serially diluted RDE-treated ferret serum were incu-
bated with 50 TCID50 of the indicated virus at 33 8C for 1 h
and then added to monolayers of MDCK cells in 96-well
plates. After incubation for 6 days at 33 8C, the cells were
examined for cytopathic effects (CPE) and the antibody titer
was defined as the reciprocal of the highest serum dilution
that completely inhibited CPE.Acknowledgments
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